Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CNDP1 antisense RNA 1 (CNDP1-AS1) is presumed to be a non-coding RNA transcribed antisense to the CNDP1 gene; however, there are no data in the provided sources supporting a functional, disease, or pharmacological role for this gene. The majority of available information and biomolecular relevance, including disease and therapeutic targeting, instead pertain to the protein-coding gene CNDP1 (Carnosine dipeptidase 1)[1][2][3][5]. CNDP1-AS1 does not appear in drug or target databases and is not characterized as a cell surface receptor, enzyme, transporter, or similar therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CNDP1 antisense RNA 1 (CNDP1-AS1).